FORMULATION AND EVALUATION OF SOLID LIPID NANOPARTICLES CONTAINING CAFFEINE TO TREAT CLINICAL MASTITIS

  • AMRUTHA U Department of Pharmaceutics, Dr. K.V. Subba Reddy Institute of Pharmacy, Dupadu, Kurnool, Andhra Pradesh.
  • SUSHMITHA B Department of Pharmaceutics, Dr. K.V. Subba Reddy Institute of Pharmacy, Dupadu, Kurnool, Andhra Pradesh.
  • SHAIK RUBINA Department of Pharmaceutics, Dr. K.V. Subba Reddy Institute of Pharmacy, Dupadu, Kurnool, Andhra Pradesh.
  • PADMINI IRIVENTI Department of Pharmaceutics, Dr. K.V. Subba Reddy Institute of Pharmacy, Dupadu, Kurnool, Andhra Pradesh.

Abstract

Objective: The objective of the present study was to formulate and evaluate caffeine loaded solid lipid nanoparticles (SLNs) in the treatment of clinical mastitis.


Methodology: These were prepared by homogenization technique using cholesterol, tween 80, and chloroform as excipients. Preformulation studies such as ultraviolet spectrophotometry, Fourier transform infrared (FTIR), and differential scanning calorimetry (DSC) were performed for the drug. Entrapment efficiency and in vitro dissolution studies were carried out for prepared SLN’s and the optimum formulation (F2) was taken for further studies such as FTIR, DSC, scanning electron microscopy, particle size, and zeta potential analysis.


Results: Obtained results stated that prepared SLNs are roughly spherical in nature and are in nanorange. These were incorporated in Carbopol gel and further evaluation studies such as pH, spreadability, viscosity, homogeneity, and in vitro drug diffusion studies were carried out. All the results obtained state that prepared nanogel has shown sustained release of drug. The antimicrobial study was carried out using Staphylococcus aureus and it was confirmed by appearance of the zone of inhibition.


Conclusion: Nanogel that contains Caffeine SLNs with 1:2 ratio drug:lipid has shown good in vitro release. Sustained release of Caffeine drug till 12 h was achieved by delivering it in the form of nanogel.

Keywords: Caffeine, Cholesterol, Clinical mastitis, Solid lipid nanoparticles, Antimicrobial activity

References

1. Hogg BB. Puerperal Mastitis. Alabama: Global Library of Women’s Medicine; 2008.
2. Dopfer D, Barkema MW, Lam TJ, Schukken YM, Gaastra W. Recurrent clinical mastitis caused by Escherichia coli in dairy cows. J Dairy Sci 1999;82:80-5.
3. Constable PD, Morin DE. Treatment of clinical mastitis. Using antimicrobial susceptibility profiles for treatment decisions. Vet Clin North Am Food Anim Pract 2003;19:139-55.
4. MacDiarmid SC. Antibacterial drugs used against mastitis in cattle by the systemic route. N Z Vet J 1978;26:290-5.
5. Nawrot P, Jordan S, Rotstein J, Hugenholtz A, Feeley M. Effects of caffeine on human health. Food Addit Contam 2003;20:1-30.
6. Alireza B, Alaleh R, Mohammad MF, Saeed S, Marzieh A, Ahmed N. The role of caffeine in pain management: A brief literature review. Anesth Pain Med 2016;6:e33193.
7. Boushey HA. Bronchodilators and other agents used in asthama. In: Katzung BG, editor. Basic and Clinical Pharmacology. 7th ed. Los Altos, CA: Appletion and Lange; 1998. p. 330-7.
8. Alashqar M, Goldstein N. Caffeine in the Treatment of Atopic Dermatitis and Psoriasis: A Review. London: International Congress Psoriasis: From Gene to Clinic; 2017. p. 77.
9. Ratwat MK, Jain A, Singh S. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: In vitro and in vivo evaluation. J Pharm Sci 2011;100:2366-78.
10. Anu M, Satvinder K. Design, formulation, and characterization of stearic acid-based solid lipid nanoparticles of candesartan cilexetil to augment its oral bioavailability. Asian J Pharm Clin Res 2018;11:344-50.
11. Dantas MG, Reis SA, Damasceno CM, Rolim LA, Rolim-Neto PJ, Carvalho FO, et al. Development and evaluation of stability of a gel formulation containing the monoterpene borneol. Sci World J 2016;2016:7394685.
12. Subhash CB, Nagaraju R, Saritha D, Sailakshmi B, Srikanth R. Formulation and evaluation of lansoprazole loaded nanosponges. Turk J Pharm Sci 2016;13:304-10.
13. Phatak AA, Chaudhari PD. Development and evaluation of nanogel as a carrier for transdermal delivery of aceclofenac. Asian J Pharm Technol 2012;2:125-32.
14. Bakhtiary J, Barar A, Aghanejad AA, Saei E, Nemati J, Ezzati ND, et al. Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer. Drug Dev Ind Pharm 2017;43:1244-53.
15. Mona MA, Amira MM. Solid lipid nanoparticles and nanostructured lipid carriers of tolnaftate: Design, optimization and in-vitro evaluation. Int J Pharm Pharm Sci 2016;8:380-5.
16. Yasmin BM, Prathyusha RG. Formulation and evaluation of dasatinib loaded solid lipid nanoparticles. Int J Pharm Pharm Sci 2018;10:14-20.
17. Sheikh SR, Abdul BA. Development and evaluation of mucoadhesive nanogel of nevirapine for vaginal application. Int J Appl Pharm 2019;11:144-9.
18. Mahendra AG, Rasika DB. Formulation and evaluation of topical anti-inflammatory herbal gel. Asian J Pharm Clin Res 2019;12:252-5.
19. Halima S, Rachida A, Fatima ZE. Antioxidant and antibacterial activities of six Algerian medicinal plants. Int J Pharm Pharm Sci 2016;8:367-74.
Statistics
59 Views | 78 Downloads
Citatons
How to Cite
U, A., S. B, S. RUBINA, and P. IRIVENTI. “FORMULATION AND EVALUATION OF SOLID LIPID NANOPARTICLES CONTAINING CAFFEINE TO TREAT CLINICAL MASTITIS”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 13, no. 7, Apr. 2020, pp. 72-78, doi:10.22159/ajpcr.2020.v13i7.37642.
Section
Original Article(s)